Logo image
Back
Conjoint Statement of the SNM, ACNM, and ABNM on credentialing and delineation of privileges for therapeutic procedures using radiopharmaceuticals
Journal article   Open access   Peer reviewed

Conjoint Statement of the SNM, ACNM, and ABNM on credentialing and delineation of privileges for therapeutic procedures using radiopharmaceuticals

Dominique Delbeke, Michael Graham, Henry Royal, George Segall, Barry L Shulkin, Harvey A Ziessman and American College of Nuclear Medicine
The Journal of nuclear medicine (1978), Vol.52(2), pp.323-326
02/01/2011
DOI: 10.2967/jnumed.110.084962
PMID: 21270458
url
https://doi.org/10.2967/jnumed.110.084962View
Published (Version of record) Open Access

Abstract

The training requirements for the supervision and administration of therapeutic procedures using radiopharmaceuticals are not defined uniformly in the Accreditation Council of Graduate Medical Education (ACGME) program requirements for different specialties. The training requirements of the Nuclear Regulatory Commission (NRC) are intended for the safe handling of radioisotopes, which is only a prerequisite to the safe practice of medicine. The purpose of this document is to recommend the minimum training requirements for therapeutic procedures using radiopharmaceuticals. These requirements should be uniform across ACGME specialty training requirements. This training must include independently evaluating and treating, under supervision, a minimum of 10 cases of radioiodine therapy for hyperthyroidism, a minimum of 5 cases of radioiodine therapy for thyroid carcinoma, and a minimum of 3 cases of parenteral radionuclide therapy. Less training and experience is inadequate to ensure the safety, appropriateness, and effectiveness of radionuclide therapy.

Details

Metrics

9 Record Views
6 Times Cited - Web of Science
Logo image